( NASDAQ-NMS:GRFS, SpanishCats:GRF, OTC-PINK:GIKLY, SpanishCats:GRF.P )

News from Grifols A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 22, 2017, 08:00 ET Grifols Phocus Rx® Pharmacy Workflow Management Solution Now Integrates With Top Hospital Information Systems via HL7 Interfaces

- Phocus Rx® enhances safety and improves hospital pharmacy workflow efficiencies with real-time electronic data warehousing and...


Aug 01, 2017, 08:00 ET Select American Red Cross Blood Donations Screened for Babesia Parasite Using Grifols' Procleix Babesia Assay Under an Investigational New Drug Protocol

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a leading global producer of plasma-derived medicines and a leader in the development of...


Jun 23, 2017, 05:00 ET Grifols añade a su cartera de productos moleculares el test de diagnóstico ID RHD XT

- Grifols recibe la autorización de marcado CE para el ID RHD XT - Al detectar las variantes más relevantes del gen RHD, este test de diagnóstico...


Jun 23, 2017, 05:00 ET Grifols ergänzt sein Molekular-Portfolio mit ID RHD XT Diagnostik-Kit

- Grifols erhält CE-Kennzeichnung für ID RHD XT - Das Diagnostik-Kit erkennt die wichtigsten RHD-Varianten und ermöglicht eine rationellere...


Jun 23, 2017, 05:00 ET Grifols aggiunge il kit diagnostico ID RHD XT al suo portafoglio molecolare

- Grifols ha ricevuto l'approvazione del marchio CE per ID RHD XT - Il kit diagnostico individua le varianti più rilevanti del RHD permettendo...


Jun 23, 2017, 05:00 ET Grifols ajoute le kit de diagnostic ID RHD XT à son portefeuille moléculaire

- Grifols reçoit la marque d'homologation CE pour l'ID RHD XT - Le kit de diagnostic détecte les variantes RHD les plus pertinentes, permettant...


Jun 22, 2017, 15:11 ET Grifols Continues to Strengthen its Diagnostic Division by Launching New Global Testing Services for the Measurement of Biological Drug Levels and Anti-Drug Immune Response in Blood Samples

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a leading global producer of plasma-derived medicines, and a leader in the development of...


Jun 12, 2017, 05:00 ET Grifols annuncia il lancio di Erytra Eflexis, l'ultima novità in soluzioni di tipizzazione dei gruppi sanguigni scalabili, adatta alle molteplici esigenze di workflow dei laboratori

- Erytra Eflexis è un sistema di analisi completamente automatico e compatto per eseguire prove di compatibilità pre-trasfusionali - Il sistema...


Jun 12, 2017, 05:00 ET Grifols anuncia el lanzamiento de Erytra Eflexis, el último avance en soluciones escalables para tipaje sanguíneo

- El Erytra Eflexis es un analizador de formato medio y totalmente automatizado que efectúa pruebas de compatibilidad previas a las transfusiones....


Jun 12, 2017, 05:00 ET Grifols annonce le lancement d'Erytra Eflexis, l'avancée la plus récente en matière de solutions évolutives de détermination des groupes sanguins qui s'adapte facilement aux différents besoins des flux de travail des laboratoires

- Erytra Eflexis est un analyseur entièrement automatisé de taille moyenne qui effectue des tests de compatibilité avant les transfusions - Ce...


Jun 12, 2017, 05:00 ET Grifols gibt die Verfügbarkeit von Erytra Eflexis bekannt, der neuesten Weiterentwicklung von skalierbarer Blutgruppenbestimmung, die sich problemlos an die verschiedenen Anforderungen von Arbeitsflüssen im Labor anpasst

- Erytra Eflexis ist ein voll automatisiertes, mittelgroßes Analysegerät, das prätransfusionelle Kompatibilitätstests durchführt - Dieses System...


Jun 12, 2017, 04:00 ET Grifols and Beckman Coulter Enter into an Exclusive Distribution Agreement

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), one of the world's leading producers of plasma-derived medicines and a leader in the...


May 23, 2017, 05:00 ET Grifols pone a disposición de los países que aceptan la marca CE su prueba de detección en sangre del virus Zika

- Grifols refuerza su cartera de productos Procleix® con la Conformidad Europea para esta prueba - A partir de ahora, los bancos de sangre en...


May 23, 2017, 05:00 ET Grifols stellt Procleix Zika Virus Testkit bereit

- Grifols stärkt sein Procleix-Portfolio mit der CE-Kennzeichnung für Procleix Zika Virus Assay - Blutbanken in Ländern, die die CE-Kennzeichnung*...


May 23, 2017, 05:00 ET Grifols met à la disposition des pays exigeant des tests marqués CE le test Procleix Zika Virus Assay** pour le dépistage du virus Zika sur les dons de sang

- Grifols renforce sa gamme de tests Procleix® par le marquage CE du test Procleix® Zika Virus Assay - Les banques du sang dans les pays exigeant...


May 09, 2017, 10:00 ET Investigational New Drug Application is Now Effective for Babesia Screening in Blood Donations Using Grifols Procleix Panther System in the US

- Test is designed to detect the presence in whole blood, of the four clinically relevant species of Babesia (B. microti, B. duncani, B....


Apr 24, 2017, 08:00 ET Grifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year Extension of OraSure Technologies Agreement and a New Manufacturing Facility

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a global healthcare company with a history of more than 75 years of improving people's health and...


Apr 17, 2017, 09:00 ET Grifols fait un don de 140 millions d'UI de facteurs de coagulation au Programme d'aide humanitaire de la Fédération mondiale de l'hémophilie

Contribution au traitement de dizaines de milliers de patients dans les pays en développement, renouvellement du partenariat avec la FMH et...


Apr 17, 2017, 09:00 ET A Grifols Doa 140 Milhões de Unidades Internacionais de Fatores da Coagulação Sanguínea ao Programa de Ajuda Humanitária da Federação Mundial de Hemofilia

Ajudar a tratar dezenas de milhares de doentes em países em desenvolvimento; renovar a parceria com a WFH; reafirmar o compromisso de melhorar as...


Apr 17, 2017, 09:00 ET Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Hemophilia Humanitarian Aid Program

Helping treat tens-of-thousands of patients in developing countries; renewing partnership with WFH; reaffirming commitment to improving the lives...


Apr 17, 2017, 09:00 ET Grifols dona 140 millones de unidades de factor de coagulación al Programa de Ayuda Humanitaria de la Federación Mundial de Hemofilia

La compañía renueva su colaboración con la FMH, reafirma su compromiso de mejorar la vida de los pacientes de todo el mundo y ayuda para que miles...


Apr 17, 2017, 09:00 ET Grifols dona farmaci a base di fattori coagulanti per 140 milioni di unità internazionali al programma di aiuti umanitari della World Federation of Hemophilia

Contribuire alla cura di decine di migliaia di pazienti nei paesi in via di sviluppo; rinnovata la partnership con la WFH; ribadito l'impegno a...


Apr 17, 2017, 09:00 ET A Grifols Doa 140 Milhões de Unidades Internacionais de Fatores da Coagulação Sanguínea ao Programa de Ajuda Humanitária da Federação Mundial de Hemofilia

Ajudar a tratar dezenas de milhares de doentes em países em desenvolvimento; renovar a parceria com a WFH; reafirmar o compromisso de melhorar as...


Apr 17, 2017, 09:00 ET Grifols spendet 140 Millionen Internationale Einheiten von Blutgerinnungsfaktoren an das Humanitarian Aid Program der World Federation of Hemophilia

- Unterstützung hilft bei der Behandlung von Zehntausenden von Patienten in Entwicklungsländern - Verlängerung der Partnerschaft mit der World...


Apr 04, 2017, 09:11 ET Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017

Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) announced that it has filed its 2016 Annual Report on Form 20-F with the United...